Global Peripheral Parenteral Nutrition (PPN) Supply, Demand and Key Producers, 2026-2032
The global Peripheral Parenteral Nutrition (PPN) market size is expected to reach $ 1894 million by 2032, rising at a market growth of 5.7% CAGR during the forecast period (2026-2032).
Peripheral Parenteral Nutrition (PPN) Solutions are sterile intravenous nutritional formulations administered through peripheral veins to provide short-term or partial nutritional support for patients who cannot fully meet nutritional needs through oral or enteral intake. PPN solutions usually contain amino acids, glucose, lipid emulsions, electrolytes, vitamins, trace elements, and sterile water, but their osmolarity and nutrient concentration are generally lower than central parenteral nutrition formulations. They are mainly used for perioperative nutrition support, temporary feeding interruption, mild to moderate malnutrition, gastrointestinal dysfunction, oncology care, emergency supplementation, and patients who do not require central venous access.The industrial chain of Peripheral Parenteral Nutrition (PPN) Solutions includes upstream amino acids, glucose, lipid emulsions, electrolytes, vitamins, trace elements, sterile water, pharmaceutical packaging materials, multi-chamber bags, infusion ports, aseptic filling materials, sterilization systems, and quality-control reagents. The midstream consists of pharmaceutical manufacturers integrating formulation development, sterile compounding, aseptic filling, bag sealing, sterilization, inspection, labeling, packaging, and batch release into finished PPN solution products. Downstream applications mainly include hospitals, surgical wards, oncology departments, gastroenterology departments, emergency care, outpatient infusion centers, home infusion services, long-term care facilities, and clinical nutrition departments. Related services include prescription adjustment, pharmacy compounding, cold-chain logistics, patient monitoring, training, clinical nutrition support, and adverse-event management.The gross profit margin of major companies in the industry was between 35%?55%.
The Peripheral Parenteral Nutrition (PPN) Solution market is mainly driven by short-term clinical nutrition support, perioperative nutrition management, gastrointestinal dysfunction treatment, oncology care, emergency supplementation, and increasing use of standardized ready-to-use nutrition bags. As hospitals seek safer and more convenient nutrition therapy for patients who do not require central venous access, demand for sterile PPN solutions continues to increase. Compared with TPN, PPN is more suitable for short-duration and lower-concentration nutritional supplementation, making it useful in surgical recovery, temporary feeding interruption, and transitional care. Product development is moving toward safer formulations, better electrolyte balance, improved lipid emulsions, multi-chamber packaging, lower infection risk, and easier clinical preparation. Overall, the market is expected to maintain steady growth, with stronger demand from hospitals, surgical departments, oncology care, and outpatient infusion services.
This report studies the global Peripheral Parenteral Nutrition (PPN) demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Peripheral Parenteral Nutrition (PPN), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Peripheral Parenteral Nutrition (PPN) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Peripheral Parenteral Nutrition (PPN) total market, 2021-2032, (USD Million)
Global Peripheral Parenteral Nutrition (PPN) total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Peripheral Parenteral Nutrition (PPN) total market, key domestic companies, and share, (USD Million)
Global Peripheral Parenteral Nutrition (PPN) revenue by player, revenue and market share 2021-2026, (USD Million)
Global Peripheral Parenteral Nutrition (PPN) total market by Type, CAGR, 2021-2032, (USD Million)
Global Peripheral Parenteral Nutrition (PPN) total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Peripheral Parenteral Nutrition (PPN) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fresenius Kabi AG, B. Braun SE, Baxter International Inc., Otsuka ICU Medical LLC, Pfizer Inc., Otsuka Pharmaceutical Factory, Inc., Yoshindo Holdings Co., Ltd., Sichuan Kelun Pharmaceutical Co., Ltd., Haisco Pharmaceutical Group Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Peripheral Parenteral Nutrition (PPN) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Peripheral Parenteral Nutrition (PPN) Market, By Region:
1. How big is the global Peripheral Parenteral Nutrition (PPN) market?
2. What is the demand of the global Peripheral Parenteral Nutrition (PPN) market?
3. What is the year over year growth of the global Peripheral Parenteral Nutrition (PPN) market?
4. What is the total value of the global Peripheral Parenteral Nutrition (PPN) market?
5. Who are the Major Players in the global Peripheral Parenteral Nutrition (PPN) market?
6. What are the growth factors driving the market demand?
Peripheral Parenteral Nutrition (PPN) Solutions are sterile intravenous nutritional formulations administered through peripheral veins to provide short-term or partial nutritional support for patients who cannot fully meet nutritional needs through oral or enteral intake. PPN solutions usually contain amino acids, glucose, lipid emulsions, electrolytes, vitamins, trace elements, and sterile water, but their osmolarity and nutrient concentration are generally lower than central parenteral nutrition formulations. They are mainly used for perioperative nutrition support, temporary feeding interruption, mild to moderate malnutrition, gastrointestinal dysfunction, oncology care, emergency supplementation, and patients who do not require central venous access.The industrial chain of Peripheral Parenteral Nutrition (PPN) Solutions includes upstream amino acids, glucose, lipid emulsions, electrolytes, vitamins, trace elements, sterile water, pharmaceutical packaging materials, multi-chamber bags, infusion ports, aseptic filling materials, sterilization systems, and quality-control reagents. The midstream consists of pharmaceutical manufacturers integrating formulation development, sterile compounding, aseptic filling, bag sealing, sterilization, inspection, labeling, packaging, and batch release into finished PPN solution products. Downstream applications mainly include hospitals, surgical wards, oncology departments, gastroenterology departments, emergency care, outpatient infusion centers, home infusion services, long-term care facilities, and clinical nutrition departments. Related services include prescription adjustment, pharmacy compounding, cold-chain logistics, patient monitoring, training, clinical nutrition support, and adverse-event management.The gross profit margin of major companies in the industry was between 35%?55%.
The Peripheral Parenteral Nutrition (PPN) Solution market is mainly driven by short-term clinical nutrition support, perioperative nutrition management, gastrointestinal dysfunction treatment, oncology care, emergency supplementation, and increasing use of standardized ready-to-use nutrition bags. As hospitals seek safer and more convenient nutrition therapy for patients who do not require central venous access, demand for sterile PPN solutions continues to increase. Compared with TPN, PPN is more suitable for short-duration and lower-concentration nutritional supplementation, making it useful in surgical recovery, temporary feeding interruption, and transitional care. Product development is moving toward safer formulations, better electrolyte balance, improved lipid emulsions, multi-chamber packaging, lower infection risk, and easier clinical preparation. Overall, the market is expected to maintain steady growth, with stronger demand from hospitals, surgical departments, oncology care, and outpatient infusion services.
This report studies the global Peripheral Parenteral Nutrition (PPN) demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Peripheral Parenteral Nutrition (PPN), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Peripheral Parenteral Nutrition (PPN) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Peripheral Parenteral Nutrition (PPN) total market, 2021-2032, (USD Million)
Global Peripheral Parenteral Nutrition (PPN) total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Peripheral Parenteral Nutrition (PPN) total market, key domestic companies, and share, (USD Million)
Global Peripheral Parenteral Nutrition (PPN) revenue by player, revenue and market share 2021-2026, (USD Million)
Global Peripheral Parenteral Nutrition (PPN) total market by Type, CAGR, 2021-2032, (USD Million)
Global Peripheral Parenteral Nutrition (PPN) total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Peripheral Parenteral Nutrition (PPN) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fresenius Kabi AG, B. Braun SE, Baxter International Inc., Otsuka ICU Medical LLC, Pfizer Inc., Otsuka Pharmaceutical Factory, Inc., Yoshindo Holdings Co., Ltd., Sichuan Kelun Pharmaceutical Co., Ltd., Haisco Pharmaceutical Group Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Peripheral Parenteral Nutrition (PPN) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Peripheral Parenteral Nutrition (PPN) Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Single-Chamber Component or Premixed PPN Solutions
- Dual-Chamber Ready-to-Use PPN Solutions
- Three-Chamber Ready-to-Use PPN Solutions
- Low-Osmolarity PPN Solutions: below 600 mOsm/L
- Standard Peripheral PPN Solutions: 600 to below 750 mOsm/L
- Upper Peripheral-Limit PPN Solutions: 750 to 900 mOsm/L
- Amino Acid and Glucose PPN Solutions
- Amino Acid, Glucose and Electrolyte PPN Solutions
- Amino Acid, Glucose, Electrolyte and Vitamin PPN Solutions
- Amino Acid, Glucose, Lipid and Electrolyte PPN Solutions
- Amino Acid, Glucose, Lipid, Electrolyte and Vitamin PPN Solutions
- Single-Nutrient PN Component Solutions Used for PPN Compounding
- Hospital
- Home
- Fresenius Kabi AG
- B. Braun SE
- Baxter International Inc.
- Otsuka ICU Medical LLC
- Pfizer Inc.
- Otsuka Pharmaceutical Factory, Inc.
- Yoshindo Holdings Co., Ltd.
- Sichuan Kelun Pharmaceutical Co., Ltd.
- Haisco Pharmaceutical Group Co., Ltd.
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- SSY Group Limited
- Guangdong Otsuka Pharmaceutical Co., Ltd.
- China Resources Double-Crane Pharmaceutical Co., Ltd.
- JW Life Science Corporation
- Aculife Healthcare Pvt. Ltd.
- Albert David Limited
1. How big is the global Peripheral Parenteral Nutrition (PPN) market?
2. What is the demand of the global Peripheral Parenteral Nutrition (PPN) market?
3. What is the year over year growth of the global Peripheral Parenteral Nutrition (PPN) market?
4. What is the total value of the global Peripheral Parenteral Nutrition (PPN) market?
5. Who are the Major Players in the global Peripheral Parenteral Nutrition (PPN) market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Peripheral Parenteral Nutrition (PPN) Introduction
1.2 World Peripheral Parenteral Nutrition (PPN) Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Peripheral Parenteral Nutrition (PPN) Total Market by Region (by Headquarter Location)
1.3.1 World Peripheral Parenteral Nutrition (PPN) Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032)
1.3.3 China Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032)
1.3.4 Europe Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032)
1.3.5 Japan Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032)
1.3.6 South Korea Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032)
1.3.7 ASEAN Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032)
1.3.8 India Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Peripheral Parenteral Nutrition (PPN) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032)
2.2 World Peripheral Parenteral Nutrition (PPN) Consumption Value by Region
2.2.1 World Peripheral Parenteral Nutrition (PPN) Consumption Value by Region (2021-2026)
2.2.2 World Peripheral Parenteral Nutrition (PPN) Consumption Value Forecast by Region (2027-2032)
2.3 United States Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032)
2.4 China Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032)
2.5 Europe Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032)
2.6 Japan Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032)
2.7 South Korea Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032)
2.8 ASEAN Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032)
2.9 India Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032)
3 WORLD PERIPHERAL PARENTERAL NUTRITION (PPN) COMPANIES COMPETITIVE ANALYSIS
3.1 World Peripheral Parenteral Nutrition (PPN) Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Peripheral Parenteral Nutrition (PPN) Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Peripheral Parenteral Nutrition (PPN) in 2025
3.2.3 Global Concentration Ratios (CR8) for Peripheral Parenteral Nutrition (PPN) in 2025
3.3 Peripheral Parenteral Nutrition (PPN) Company Evaluation Quadrant
3.4 Peripheral Parenteral Nutrition (PPN) Market: Overall Company Footprint Analysis
3.4.1 Peripheral Parenteral Nutrition (PPN) Market: Region Footprint
3.4.2 Peripheral Parenteral Nutrition (PPN) Market: Company Product Type Footprint
3.4.3 Peripheral Parenteral Nutrition (PPN) Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Peripheral Parenteral Nutrition (PPN) Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Peripheral Parenteral Nutrition (PPN) Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Peripheral Parenteral Nutrition (PPN) Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Peripheral Parenteral Nutrition (PPN) Consumption Value Comparison
4.2.1 United States VS China: Peripheral Parenteral Nutrition (PPN) Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Peripheral Parenteral Nutrition (PPN) Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Peripheral Parenteral Nutrition (PPN) Companies and Market Share, 2021-2026
4.3.1 United States Based Peripheral Parenteral Nutrition (PPN) Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Peripheral Parenteral Nutrition (PPN) Revenue, (2021-2026)
4.4 China Based Companies Peripheral Parenteral Nutrition (PPN) Revenue and Market Share, 2021-2026
4.4.1 China Based Peripheral Parenteral Nutrition (PPN) Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Peripheral Parenteral Nutrition (PPN) Revenue, (2021-2026)
4.5 Rest of World Based Peripheral Parenteral Nutrition (PPN) Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Peripheral Parenteral Nutrition (PPN) Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Peripheral Parenteral Nutrition (PPN) Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Peripheral Parenteral Nutrition (PPN) Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Single-Chamber Component or Premixed PPN Solutions
5.2.2 Dual-Chamber Ready-to-Use PPN Solutions
5.2.3 Three-Chamber Ready-to-Use PPN Solutions
5.3 Market Segment by Type
5.3.1 World Peripheral Parenteral Nutrition (PPN) Market Size by Type (2021-2026)
5.3.2 World Peripheral Parenteral Nutrition (PPN) Market Size by Type (2027-2032)
5.3.3 World Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY OSMOTIC PRESSURE LEVEL
6.1 World Peripheral Parenteral Nutrition (PPN) Market Size Overview by Osmotic Pressure Level: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Osmotic Pressure Level
6.2.1 Low-Osmolarity PPN Solutions: below 600 mOsm/L
6.2.2 Standard Peripheral PPN Solutions: 600 to below 750 mOsm/L
6.2.3 Upper Peripheral-Limit PPN Solutions: 750 to 900 mOsm/L
6.3 Market Segment by Osmotic Pressure Level
6.3.1 World Peripheral Parenteral Nutrition (PPN) Market Size by Osmotic Pressure Level (2021-2026)
6.3.2 World Peripheral Parenteral Nutrition (PPN) Market Size by Osmotic Pressure Level (2027-2032)
6.3.3 World Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Osmotic Pressure Level (2027-2032)
7 MARKET ANALYSIS BY COMBINATION OF MAIN NUTRIENTS
7.1 World Peripheral Parenteral Nutrition (PPN) Market Size Overview by Combination of Main Nutrients: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Combination of Main Nutrients
7.2.1 Amino Acid and Glucose PPN Solutions
7.2.2 Amino Acid, Glucose and Electrolyte PPN Solutions
7.2.3 Amino Acid, Glucose, Electrolyte and Vitamin PPN Solutions
7.2.4 Amino Acid, Glucose, Lipid and Electrolyte PPN Solutions
7.2.5 Amino Acid, Glucose, Lipid, Electrolyte and Vitamin PPN Solutions
7.2.6 Single-Nutrient PN Component Solutions Used for PPN Compounding
7.3 Market Segment by Combination of Main Nutrients
7.3.1 World Peripheral Parenteral Nutrition (PPN) Market Size by Combination of Main Nutrients (2021-2026)
7.3.2 World Peripheral Parenteral Nutrition (PPN) Market Size by Combination of Main Nutrients (2027-2032)
7.3.3 World Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Combination of Main Nutrients (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Peripheral Parenteral Nutrition (PPN) Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Home
8.3 Market Segment by Application
8.3.1 World Peripheral Parenteral Nutrition (PPN) Market Size by Application (2021-2026)
8.3.2 World Peripheral Parenteral Nutrition (PPN) Market Size by Application (2027-2032)
8.3.3 World Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Fresenius Kabi AG
9.1.1 Fresenius Kabi AG Details
9.1.2 Fresenius Kabi AG Major Business
9.1.3 Fresenius Kabi AG Peripheral Parenteral Nutrition (PPN) Product and Services
9.1.4 Fresenius Kabi AG Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Fresenius Kabi AG Recent Developments/Updates
9.1.6 Fresenius Kabi AG Competitive Strengths & Weaknesses
9.2 B. Braun SE
9.2.1 B. Braun SE Details
9.2.2 B. Braun SE Major Business
9.2.3 B. Braun SE Peripheral Parenteral Nutrition (PPN) Product and Services
9.2.4 B. Braun SE Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 B. Braun SE Recent Developments/Updates
9.2.6 B. Braun SE Competitive Strengths & Weaknesses
9.3 Baxter International Inc.
9.3.1 Baxter International Inc. Details
9.3.2 Baxter International Inc. Major Business
9.3.3 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Product and Services
9.3.4 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Baxter International Inc. Recent Developments/Updates
9.3.6 Baxter International Inc. Competitive Strengths & Weaknesses
9.4 Otsuka ICU Medical LLC
9.4.1 Otsuka ICU Medical LLC Details
9.4.2 Otsuka ICU Medical LLC Major Business
9.4.3 Otsuka ICU Medical LLC Peripheral Parenteral Nutrition (PPN) Product and Services
9.4.4 Otsuka ICU Medical LLC Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Otsuka ICU Medical LLC Recent Developments/Updates
9.4.6 Otsuka ICU Medical LLC Competitive Strengths & Weaknesses
9.5 Pfizer Inc.
9.5.1 Pfizer Inc. Details
9.5.2 Pfizer Inc. Major Business
9.5.3 Pfizer Inc. Peripheral Parenteral Nutrition (PPN) Product and Services
9.5.4 Pfizer Inc. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Pfizer Inc. Recent Developments/Updates
9.5.6 Pfizer Inc. Competitive Strengths & Weaknesses
9.6 Otsuka Pharmaceutical Factory, Inc.
9.6.1 Otsuka Pharmaceutical Factory, Inc. Details
9.6.2 Otsuka Pharmaceutical Factory, Inc. Major Business
9.6.3 Otsuka Pharmaceutical Factory, Inc. Peripheral Parenteral Nutrition (PPN) Product and Services
9.6.4 Otsuka Pharmaceutical Factory, Inc. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Otsuka Pharmaceutical Factory, Inc. Recent Developments/Updates
9.6.6 Otsuka Pharmaceutical Factory, Inc. Competitive Strengths & Weaknesses
9.7 Yoshindo Holdings Co., Ltd.
9.7.1 Yoshindo Holdings Co., Ltd. Details
9.7.2 Yoshindo Holdings Co., Ltd. Major Business
9.7.3 Yoshindo Holdings Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
9.7.4 Yoshindo Holdings Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Yoshindo Holdings Co., Ltd. Recent Developments/Updates
9.7.6 Yoshindo Holdings Co., Ltd. Competitive Strengths & Weaknesses
9.8 Sichuan Kelun Pharmaceutical Co., Ltd.
9.8.1 Sichuan Kelun Pharmaceutical Co., Ltd. Details
9.8.2 Sichuan Kelun Pharmaceutical Co., Ltd. Major Business
9.8.3 Sichuan Kelun Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
9.8.4 Sichuan Kelun Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments/Updates
9.8.6 Sichuan Kelun Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
9.9 Haisco Pharmaceutical Group Co., Ltd.
9.9.1 Haisco Pharmaceutical Group Co., Ltd. Details
9.9.2 Haisco Pharmaceutical Group Co., Ltd. Major Business
9.9.3 Haisco Pharmaceutical Group Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
9.9.4 Haisco Pharmaceutical Group Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Haisco Pharmaceutical Group Co., Ltd. Recent Developments/Updates
9.9.6 Haisco Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
9.10 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
9.10.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Details
9.10.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Major Business
9.10.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
9.10.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
9.10.6 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
9.11 SSY Group Limited
9.11.1 SSY Group Limited Details
9.11.2 SSY Group Limited Major Business
9.11.3 SSY Group Limited Peripheral Parenteral Nutrition (PPN) Product and Services
9.11.4 SSY Group Limited Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 SSY Group Limited Recent Developments/Updates
9.11.6 SSY Group Limited Competitive Strengths & Weaknesses
9.12 Guangdong Otsuka Pharmaceutical Co., Ltd.
9.12.1 Guangdong Otsuka Pharmaceutical Co., Ltd. Details
9.12.2 Guangdong Otsuka Pharmaceutical Co., Ltd. Major Business
9.12.3 Guangdong Otsuka Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
9.12.4 Guangdong Otsuka Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Guangdong Otsuka Pharmaceutical Co., Ltd. Recent Developments/Updates
9.12.6 Guangdong Otsuka Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
9.13 China Resources Double-Crane Pharmaceutical Co., Ltd.
9.13.1 China Resources Double-Crane Pharmaceutical Co., Ltd. Details
9.13.2 China Resources Double-Crane Pharmaceutical Co., Ltd. Major Business
9.13.3 China Resources Double-Crane Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
9.13.4 China Resources Double-Crane Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 China Resources Double-Crane Pharmaceutical Co., Ltd. Recent Developments/Updates
9.13.6 China Resources Double-Crane Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
9.14 JW Life Science Corporation
9.14.1 JW Life Science Corporation Details
9.14.2 JW Life Science Corporation Major Business
9.14.3 JW Life Science Corporation Peripheral Parenteral Nutrition (PPN) Product and Services
9.14.4 JW Life Science Corporation Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 JW Life Science Corporation Recent Developments/Updates
9.14.6 JW Life Science Corporation Competitive Strengths & Weaknesses
9.15 Aculife Healthcare Pvt. Ltd.
9.15.1 Aculife Healthcare Pvt. Ltd. Details
9.15.2 Aculife Healthcare Pvt. Ltd. Major Business
9.15.3 Aculife Healthcare Pvt. Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
9.15.4 Aculife Healthcare Pvt. Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Aculife Healthcare Pvt. Ltd. Recent Developments/Updates
9.15.6 Aculife Healthcare Pvt. Ltd. Competitive Strengths & Weaknesses
9.16 Albert David Limited
9.16.1 Albert David Limited Details
9.16.2 Albert David Limited Major Business
9.16.3 Albert David Limited Peripheral Parenteral Nutrition (PPN) Product and Services
9.16.4 Albert David Limited Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Albert David Limited Recent Developments/Updates
9.16.6 Albert David Limited Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Peripheral Parenteral Nutrition (PPN) Industry Chain
10.2 Peripheral Parenteral Nutrition (PPN) Upstream Analysis
10.3 Peripheral Parenteral Nutrition (PPN) Midstream Analysis
10.4 Peripheral Parenteral Nutrition (PPN) Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Peripheral Parenteral Nutrition (PPN) Introduction
1.2 World Peripheral Parenteral Nutrition (PPN) Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Peripheral Parenteral Nutrition (PPN) Total Market by Region (by Headquarter Location)
1.3.1 World Peripheral Parenteral Nutrition (PPN) Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032)
1.3.3 China Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032)
1.3.4 Europe Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032)
1.3.5 Japan Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032)
1.3.6 South Korea Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032)
1.3.7 ASEAN Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032)
1.3.8 India Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Peripheral Parenteral Nutrition (PPN) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032)
2.2 World Peripheral Parenteral Nutrition (PPN) Consumption Value by Region
2.2.1 World Peripheral Parenteral Nutrition (PPN) Consumption Value by Region (2021-2026)
2.2.2 World Peripheral Parenteral Nutrition (PPN) Consumption Value Forecast by Region (2027-2032)
2.3 United States Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032)
2.4 China Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032)
2.5 Europe Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032)
2.6 Japan Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032)
2.7 South Korea Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032)
2.8 ASEAN Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032)
2.9 India Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032)
3 WORLD PERIPHERAL PARENTERAL NUTRITION (PPN) COMPANIES COMPETITIVE ANALYSIS
3.1 World Peripheral Parenteral Nutrition (PPN) Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Peripheral Parenteral Nutrition (PPN) Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Peripheral Parenteral Nutrition (PPN) in 2025
3.2.3 Global Concentration Ratios (CR8) for Peripheral Parenteral Nutrition (PPN) in 2025
3.3 Peripheral Parenteral Nutrition (PPN) Company Evaluation Quadrant
3.4 Peripheral Parenteral Nutrition (PPN) Market: Overall Company Footprint Analysis
3.4.1 Peripheral Parenteral Nutrition (PPN) Market: Region Footprint
3.4.2 Peripheral Parenteral Nutrition (PPN) Market: Company Product Type Footprint
3.4.3 Peripheral Parenteral Nutrition (PPN) Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Peripheral Parenteral Nutrition (PPN) Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Peripheral Parenteral Nutrition (PPN) Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Peripheral Parenteral Nutrition (PPN) Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Peripheral Parenteral Nutrition (PPN) Consumption Value Comparison
4.2.1 United States VS China: Peripheral Parenteral Nutrition (PPN) Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Peripheral Parenteral Nutrition (PPN) Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Peripheral Parenteral Nutrition (PPN) Companies and Market Share, 2021-2026
4.3.1 United States Based Peripheral Parenteral Nutrition (PPN) Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Peripheral Parenteral Nutrition (PPN) Revenue, (2021-2026)
4.4 China Based Companies Peripheral Parenteral Nutrition (PPN) Revenue and Market Share, 2021-2026
4.4.1 China Based Peripheral Parenteral Nutrition (PPN) Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Peripheral Parenteral Nutrition (PPN) Revenue, (2021-2026)
4.5 Rest of World Based Peripheral Parenteral Nutrition (PPN) Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Peripheral Parenteral Nutrition (PPN) Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Peripheral Parenteral Nutrition (PPN) Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Peripheral Parenteral Nutrition (PPN) Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Single-Chamber Component or Premixed PPN Solutions
5.2.2 Dual-Chamber Ready-to-Use PPN Solutions
5.2.3 Three-Chamber Ready-to-Use PPN Solutions
5.3 Market Segment by Type
5.3.1 World Peripheral Parenteral Nutrition (PPN) Market Size by Type (2021-2026)
5.3.2 World Peripheral Parenteral Nutrition (PPN) Market Size by Type (2027-2032)
5.3.3 World Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY OSMOTIC PRESSURE LEVEL
6.1 World Peripheral Parenteral Nutrition (PPN) Market Size Overview by Osmotic Pressure Level: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Osmotic Pressure Level
6.2.1 Low-Osmolarity PPN Solutions: below 600 mOsm/L
6.2.2 Standard Peripheral PPN Solutions: 600 to below 750 mOsm/L
6.2.3 Upper Peripheral-Limit PPN Solutions: 750 to 900 mOsm/L
6.3 Market Segment by Osmotic Pressure Level
6.3.1 World Peripheral Parenteral Nutrition (PPN) Market Size by Osmotic Pressure Level (2021-2026)
6.3.2 World Peripheral Parenteral Nutrition (PPN) Market Size by Osmotic Pressure Level (2027-2032)
6.3.3 World Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Osmotic Pressure Level (2027-2032)
7 MARKET ANALYSIS BY COMBINATION OF MAIN NUTRIENTS
7.1 World Peripheral Parenteral Nutrition (PPN) Market Size Overview by Combination of Main Nutrients: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Combination of Main Nutrients
7.2.1 Amino Acid and Glucose PPN Solutions
7.2.2 Amino Acid, Glucose and Electrolyte PPN Solutions
7.2.3 Amino Acid, Glucose, Electrolyte and Vitamin PPN Solutions
7.2.4 Amino Acid, Glucose, Lipid and Electrolyte PPN Solutions
7.2.5 Amino Acid, Glucose, Lipid, Electrolyte and Vitamin PPN Solutions
7.2.6 Single-Nutrient PN Component Solutions Used for PPN Compounding
7.3 Market Segment by Combination of Main Nutrients
7.3.1 World Peripheral Parenteral Nutrition (PPN) Market Size by Combination of Main Nutrients (2021-2026)
7.3.2 World Peripheral Parenteral Nutrition (PPN) Market Size by Combination of Main Nutrients (2027-2032)
7.3.3 World Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Combination of Main Nutrients (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Peripheral Parenteral Nutrition (PPN) Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Home
8.3 Market Segment by Application
8.3.1 World Peripheral Parenteral Nutrition (PPN) Market Size by Application (2021-2026)
8.3.2 World Peripheral Parenteral Nutrition (PPN) Market Size by Application (2027-2032)
8.3.3 World Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Fresenius Kabi AG
9.1.1 Fresenius Kabi AG Details
9.1.2 Fresenius Kabi AG Major Business
9.1.3 Fresenius Kabi AG Peripheral Parenteral Nutrition (PPN) Product and Services
9.1.4 Fresenius Kabi AG Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Fresenius Kabi AG Recent Developments/Updates
9.1.6 Fresenius Kabi AG Competitive Strengths & Weaknesses
9.2 B. Braun SE
9.2.1 B. Braun SE Details
9.2.2 B. Braun SE Major Business
9.2.3 B. Braun SE Peripheral Parenteral Nutrition (PPN) Product and Services
9.2.4 B. Braun SE Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 B. Braun SE Recent Developments/Updates
9.2.6 B. Braun SE Competitive Strengths & Weaknesses
9.3 Baxter International Inc.
9.3.1 Baxter International Inc. Details
9.3.2 Baxter International Inc. Major Business
9.3.3 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Product and Services
9.3.4 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Baxter International Inc. Recent Developments/Updates
9.3.6 Baxter International Inc. Competitive Strengths & Weaknesses
9.4 Otsuka ICU Medical LLC
9.4.1 Otsuka ICU Medical LLC Details
9.4.2 Otsuka ICU Medical LLC Major Business
9.4.3 Otsuka ICU Medical LLC Peripheral Parenteral Nutrition (PPN) Product and Services
9.4.4 Otsuka ICU Medical LLC Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Otsuka ICU Medical LLC Recent Developments/Updates
9.4.6 Otsuka ICU Medical LLC Competitive Strengths & Weaknesses
9.5 Pfizer Inc.
9.5.1 Pfizer Inc. Details
9.5.2 Pfizer Inc. Major Business
9.5.3 Pfizer Inc. Peripheral Parenteral Nutrition (PPN) Product and Services
9.5.4 Pfizer Inc. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Pfizer Inc. Recent Developments/Updates
9.5.6 Pfizer Inc. Competitive Strengths & Weaknesses
9.6 Otsuka Pharmaceutical Factory, Inc.
9.6.1 Otsuka Pharmaceutical Factory, Inc. Details
9.6.2 Otsuka Pharmaceutical Factory, Inc. Major Business
9.6.3 Otsuka Pharmaceutical Factory, Inc. Peripheral Parenteral Nutrition (PPN) Product and Services
9.6.4 Otsuka Pharmaceutical Factory, Inc. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Otsuka Pharmaceutical Factory, Inc. Recent Developments/Updates
9.6.6 Otsuka Pharmaceutical Factory, Inc. Competitive Strengths & Weaknesses
9.7 Yoshindo Holdings Co., Ltd.
9.7.1 Yoshindo Holdings Co., Ltd. Details
9.7.2 Yoshindo Holdings Co., Ltd. Major Business
9.7.3 Yoshindo Holdings Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
9.7.4 Yoshindo Holdings Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Yoshindo Holdings Co., Ltd. Recent Developments/Updates
9.7.6 Yoshindo Holdings Co., Ltd. Competitive Strengths & Weaknesses
9.8 Sichuan Kelun Pharmaceutical Co., Ltd.
9.8.1 Sichuan Kelun Pharmaceutical Co., Ltd. Details
9.8.2 Sichuan Kelun Pharmaceutical Co., Ltd. Major Business
9.8.3 Sichuan Kelun Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
9.8.4 Sichuan Kelun Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments/Updates
9.8.6 Sichuan Kelun Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
9.9 Haisco Pharmaceutical Group Co., Ltd.
9.9.1 Haisco Pharmaceutical Group Co., Ltd. Details
9.9.2 Haisco Pharmaceutical Group Co., Ltd. Major Business
9.9.3 Haisco Pharmaceutical Group Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
9.9.4 Haisco Pharmaceutical Group Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Haisco Pharmaceutical Group Co., Ltd. Recent Developments/Updates
9.9.6 Haisco Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
9.10 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
9.10.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Details
9.10.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Major Business
9.10.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
9.10.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
9.10.6 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
9.11 SSY Group Limited
9.11.1 SSY Group Limited Details
9.11.2 SSY Group Limited Major Business
9.11.3 SSY Group Limited Peripheral Parenteral Nutrition (PPN) Product and Services
9.11.4 SSY Group Limited Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 SSY Group Limited Recent Developments/Updates
9.11.6 SSY Group Limited Competitive Strengths & Weaknesses
9.12 Guangdong Otsuka Pharmaceutical Co., Ltd.
9.12.1 Guangdong Otsuka Pharmaceutical Co., Ltd. Details
9.12.2 Guangdong Otsuka Pharmaceutical Co., Ltd. Major Business
9.12.3 Guangdong Otsuka Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
9.12.4 Guangdong Otsuka Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Guangdong Otsuka Pharmaceutical Co., Ltd. Recent Developments/Updates
9.12.6 Guangdong Otsuka Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
9.13 China Resources Double-Crane Pharmaceutical Co., Ltd.
9.13.1 China Resources Double-Crane Pharmaceutical Co., Ltd. Details
9.13.2 China Resources Double-Crane Pharmaceutical Co., Ltd. Major Business
9.13.3 China Resources Double-Crane Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
9.13.4 China Resources Double-Crane Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 China Resources Double-Crane Pharmaceutical Co., Ltd. Recent Developments/Updates
9.13.6 China Resources Double-Crane Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
9.14 JW Life Science Corporation
9.14.1 JW Life Science Corporation Details
9.14.2 JW Life Science Corporation Major Business
9.14.3 JW Life Science Corporation Peripheral Parenteral Nutrition (PPN) Product and Services
9.14.4 JW Life Science Corporation Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 JW Life Science Corporation Recent Developments/Updates
9.14.6 JW Life Science Corporation Competitive Strengths & Weaknesses
9.15 Aculife Healthcare Pvt. Ltd.
9.15.1 Aculife Healthcare Pvt. Ltd. Details
9.15.2 Aculife Healthcare Pvt. Ltd. Major Business
9.15.3 Aculife Healthcare Pvt. Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
9.15.4 Aculife Healthcare Pvt. Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Aculife Healthcare Pvt. Ltd. Recent Developments/Updates
9.15.6 Aculife Healthcare Pvt. Ltd. Competitive Strengths & Weaknesses
9.16 Albert David Limited
9.16.1 Albert David Limited Details
9.16.2 Albert David Limited Major Business
9.16.3 Albert David Limited Peripheral Parenteral Nutrition (PPN) Product and Services
9.16.4 Albert David Limited Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Albert David Limited Recent Developments/Updates
9.16.6 Albert David Limited Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Peripheral Parenteral Nutrition (PPN) Industry Chain
10.2 Peripheral Parenteral Nutrition (PPN) Upstream Analysis
10.3 Peripheral Parenteral Nutrition (PPN) Midstream Analysis
10.4 Peripheral Parenteral Nutrition (PPN) Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Peripheral Parenteral Nutrition (PPN) Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Peripheral Parenteral Nutrition (PPN) Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Peripheral Parenteral Nutrition (PPN) Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Peripheral Parenteral Nutrition (PPN) Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Peripheral Parenteral Nutrition (PPN) Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Peripheral Parenteral Nutrition (PPN) Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Peripheral Parenteral Nutrition (PPN) Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Peripheral Parenteral Nutrition (PPN) Players in 2025
Table 12. World Peripheral Parenteral Nutrition (PPN) Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Peripheral Parenteral Nutrition (PPN) Company Evaluation Quadrant
Table 14. Head Office of Key Peripheral Parenteral Nutrition (PPN) Players
Table 15. Peripheral Parenteral Nutrition (PPN) Market: Company Product Type Footprint
Table 16. Peripheral Parenteral Nutrition (PPN) Market: Company Product Application Footprint
Table 17. Peripheral Parenteral Nutrition (PPN) Mergers & Acquisitions Activity
Table 18. United States VS China Peripheral Parenteral Nutrition (PPN) Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Peripheral Parenteral Nutrition (PPN) Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Peripheral Parenteral Nutrition (PPN) Companies, Headquarters (States, Country)
Table 21. United States Based Companies Peripheral Parenteral Nutrition (PPN) Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Peripheral Parenteral Nutrition (PPN) Revenue Market Share (2021-2026)
Table 23. China Based Peripheral Parenteral Nutrition (PPN) Companies, Headquarters (Province, Country)
Table 24. China Based Companies Peripheral Parenteral Nutrition (PPN) Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Peripheral Parenteral Nutrition (PPN) Revenue Market Share (2021-2026)
Table 26. Rest of World Based Peripheral Parenteral Nutrition (PPN) Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Peripheral Parenteral Nutrition (PPN) Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Peripheral Parenteral Nutrition (PPN) Revenue Market Share (2021-2026)
Table 29. World Peripheral Parenteral Nutrition (PPN) Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Peripheral Parenteral Nutrition (PPN) Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Peripheral Parenteral Nutrition (PPN) Market Size by Type (2027-2032) & (USD Million)
Table 32. World Peripheral Parenteral Nutrition (PPN) Market Size by Osmotic Pressure Level, (USD Million), 2021 & 2025 & 2032
Table 33. World Peripheral Parenteral Nutrition (PPN) Market Size Value by Osmotic Pressure Level (2021-2026) & (USD Million)
Table 34. World Peripheral Parenteral Nutrition (PPN) Market Size by Osmotic Pressure Level (2027-2032) & (USD Million)
Table 35. World Peripheral Parenteral Nutrition (PPN) Market Size by Combination of Main Nutrients, (USD Million), 2021 & 2025 & 2032
Table 36. World Peripheral Parenteral Nutrition (PPN) Market Size Value by Combination of Main Nutrients (2021-2026) & (USD Million)
Table 37. World Peripheral Parenteral Nutrition (PPN) Market Size by Combination of Main Nutrients (2027-2032) & (USD Million)
Table 38. World Peripheral Parenteral Nutrition (PPN) Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Peripheral Parenteral Nutrition (PPN) Market Size by Application (2021-2026) & (USD Million)
Table 40. World Peripheral Parenteral Nutrition (PPN) Market Size by Application (2027-2032) & (USD Million)
Table 41. Fresenius Kabi AG Basic Information, Manufacturing Base and Competitors
Table 42. Fresenius Kabi AG Major Business
Table 43. Fresenius Kabi AG Peripheral Parenteral Nutrition (PPN) Product and Services
Table 44. Fresenius Kabi AG Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Fresenius Kabi AG Recent Developments/Updates
Table 46. Fresenius Kabi AG Competitive Strengths & Weaknesses
Table 47. B. Braun SE Basic Information, Manufacturing Base and Competitors
Table 48. B. Braun SE Major Business
Table 49. B. Braun SE Peripheral Parenteral Nutrition (PPN) Product and Services
Table 50. B. Braun SE Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. B. Braun SE Recent Developments/Updates
Table 52. B. Braun SE Competitive Strengths & Weaknesses
Table 53. Baxter International Inc. Basic Information, Manufacturing Base and Competitors
Table 54. Baxter International Inc. Major Business
Table 55. Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Product and Services
Table 56. Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Baxter International Inc. Recent Developments/Updates
Table 58. Baxter International Inc. Competitive Strengths & Weaknesses
Table 59. Otsuka ICU Medical LLC Basic Information, Manufacturing Base and Competitors
Table 60. Otsuka ICU Medical LLC Major Business
Table 61. Otsuka ICU Medical LLC Peripheral Parenteral Nutrition (PPN) Product and Services
Table 62. Otsuka ICU Medical LLC Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Otsuka ICU Medical LLC Recent Developments/Updates
Table 64. Otsuka ICU Medical LLC Competitive Strengths & Weaknesses
Table 65. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 66. Pfizer Inc. Major Business
Table 67. Pfizer Inc. Peripheral Parenteral Nutrition (PPN) Product and Services
Table 68. Pfizer Inc. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Pfizer Inc. Recent Developments/Updates
Table 70. Pfizer Inc. Competitive Strengths & Weaknesses
Table 71. Otsuka Pharmaceutical Factory, Inc. Basic Information, Manufacturing Base and Competitors
Table 72. Otsuka Pharmaceutical Factory, Inc. Major Business
Table 73. Otsuka Pharmaceutical Factory, Inc. Peripheral Parenteral Nutrition (PPN) Product and Services
Table 74. Otsuka Pharmaceutical Factory, Inc. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Otsuka Pharmaceutical Factory, Inc. Recent Developments/Updates
Table 76. Otsuka Pharmaceutical Factory, Inc. Competitive Strengths & Weaknesses
Table 77. Yoshindo Holdings Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 78. Yoshindo Holdings Co., Ltd. Major Business
Table 79. Yoshindo Holdings Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
Table 80. Yoshindo Holdings Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Yoshindo Holdings Co., Ltd. Recent Developments/Updates
Table 82. Yoshindo Holdings Co., Ltd. Competitive Strengths & Weaknesses
Table 83. Sichuan Kelun Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 84. Sichuan Kelun Pharmaceutical Co., Ltd. Major Business
Table 85. Sichuan Kelun Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
Table 86. Sichuan Kelun Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 88. Sichuan Kelun Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 89. Haisco Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 90. Haisco Pharmaceutical Group Co., Ltd. Major Business
Table 91. Haisco Pharmaceutical Group Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
Table 92. Haisco Pharmaceutical Group Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Haisco Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 94. Haisco Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
Table 95. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 96. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Major Business
Table 97. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
Table 98. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 100. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
Table 101. SSY Group Limited Basic Information, Manufacturing Base and Competitors
Table 102. SSY Group Limited Major Business
Table 103. SSY Group Limited Peripheral Parenteral Nutrition (PPN) Product and Services
Table 104. SSY Group Limited Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. SSY Group Limited Recent Developments/Updates
Table 106. SSY Group Limited Competitive Strengths & Weaknesses
Table 107. Guangdong Otsuka Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 108. Guangdong Otsuka Pharmaceutical Co., Ltd. Major Business
Table 109. Guangdong Otsuka Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
Table 110. Guangdong Otsuka Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Guangdong Otsuka Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 112. Guangdong Otsuka Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 113. China Resources Double-Crane Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 114. China Resources Double-Crane Pharmaceutical Co., Ltd. Major Business
Table 115. China Resources Double-Crane Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
Table 116. China Resources Double-Crane Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. China Resources Double-Crane Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 118. China Resources Double-Crane Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 119. JW Life Science Corporation Basic Information, Manufacturing Base and Competitors
Table 120. JW Life Science Corporation Major Business
Table 121. JW Life Science Corporation Peripheral Parenteral Nutrition (PPN) Product and Services
Table 122. JW Life Science Corporation Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. JW Life Science Corporation Recent Developments/Updates
Table 124. JW Life Science Corporation Competitive Strengths & Weaknesses
Table 125. Aculife Healthcare Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 126. Aculife Healthcare Pvt. Ltd. Major Business
Table 127. Aculife Healthcare Pvt. Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
Table 128. Aculife Healthcare Pvt. Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Aculife Healthcare Pvt. Ltd. Recent Developments/Updates
Table 130. Aculife Healthcare Pvt. Ltd. Competitive Strengths & Weaknesses
Table 131. Albert David Limited Basic Information, Manufacturing Base and Competitors
Table 132. Albert David Limited Major Business
Table 133. Albert David Limited Peripheral Parenteral Nutrition (PPN) Product and Services
Table 134. Albert David Limited Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Albert David Limited Recent Developments/Updates
Table 136. Albert David Limited Competitive Strengths & Weaknesses
Table 137. Global Key Players of Peripheral Parenteral Nutrition (PPN) Upstream (Raw Materials)
Table 138. Global Peripheral Parenteral Nutrition (PPN) Typical Customers
Table 1. World Peripheral Parenteral Nutrition (PPN) Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Peripheral Parenteral Nutrition (PPN) Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Peripheral Parenteral Nutrition (PPN) Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Peripheral Parenteral Nutrition (PPN) Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Peripheral Parenteral Nutrition (PPN) Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Peripheral Parenteral Nutrition (PPN) Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Peripheral Parenteral Nutrition (PPN) Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Peripheral Parenteral Nutrition (PPN) Players in 2025
Table 12. World Peripheral Parenteral Nutrition (PPN) Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Peripheral Parenteral Nutrition (PPN) Company Evaluation Quadrant
Table 14. Head Office of Key Peripheral Parenteral Nutrition (PPN) Players
Table 15. Peripheral Parenteral Nutrition (PPN) Market: Company Product Type Footprint
Table 16. Peripheral Parenteral Nutrition (PPN) Market: Company Product Application Footprint
Table 17. Peripheral Parenteral Nutrition (PPN) Mergers & Acquisitions Activity
Table 18. United States VS China Peripheral Parenteral Nutrition (PPN) Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Peripheral Parenteral Nutrition (PPN) Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Peripheral Parenteral Nutrition (PPN) Companies, Headquarters (States, Country)
Table 21. United States Based Companies Peripheral Parenteral Nutrition (PPN) Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Peripheral Parenteral Nutrition (PPN) Revenue Market Share (2021-2026)
Table 23. China Based Peripheral Parenteral Nutrition (PPN) Companies, Headquarters (Province, Country)
Table 24. China Based Companies Peripheral Parenteral Nutrition (PPN) Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Peripheral Parenteral Nutrition (PPN) Revenue Market Share (2021-2026)
Table 26. Rest of World Based Peripheral Parenteral Nutrition (PPN) Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Peripheral Parenteral Nutrition (PPN) Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Peripheral Parenteral Nutrition (PPN) Revenue Market Share (2021-2026)
Table 29. World Peripheral Parenteral Nutrition (PPN) Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Peripheral Parenteral Nutrition (PPN) Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Peripheral Parenteral Nutrition (PPN) Market Size by Type (2027-2032) & (USD Million)
Table 32. World Peripheral Parenteral Nutrition (PPN) Market Size by Osmotic Pressure Level, (USD Million), 2021 & 2025 & 2032
Table 33. World Peripheral Parenteral Nutrition (PPN) Market Size Value by Osmotic Pressure Level (2021-2026) & (USD Million)
Table 34. World Peripheral Parenteral Nutrition (PPN) Market Size by Osmotic Pressure Level (2027-2032) & (USD Million)
Table 35. World Peripheral Parenteral Nutrition (PPN) Market Size by Combination of Main Nutrients, (USD Million), 2021 & 2025 & 2032
Table 36. World Peripheral Parenteral Nutrition (PPN) Market Size Value by Combination of Main Nutrients (2021-2026) & (USD Million)
Table 37. World Peripheral Parenteral Nutrition (PPN) Market Size by Combination of Main Nutrients (2027-2032) & (USD Million)
Table 38. World Peripheral Parenteral Nutrition (PPN) Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Peripheral Parenteral Nutrition (PPN) Market Size by Application (2021-2026) & (USD Million)
Table 40. World Peripheral Parenteral Nutrition (PPN) Market Size by Application (2027-2032) & (USD Million)
Table 41. Fresenius Kabi AG Basic Information, Manufacturing Base and Competitors
Table 42. Fresenius Kabi AG Major Business
Table 43. Fresenius Kabi AG Peripheral Parenteral Nutrition (PPN) Product and Services
Table 44. Fresenius Kabi AG Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Fresenius Kabi AG Recent Developments/Updates
Table 46. Fresenius Kabi AG Competitive Strengths & Weaknesses
Table 47. B. Braun SE Basic Information, Manufacturing Base and Competitors
Table 48. B. Braun SE Major Business
Table 49. B. Braun SE Peripheral Parenteral Nutrition (PPN) Product and Services
Table 50. B. Braun SE Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. B. Braun SE Recent Developments/Updates
Table 52. B. Braun SE Competitive Strengths & Weaknesses
Table 53. Baxter International Inc. Basic Information, Manufacturing Base and Competitors
Table 54. Baxter International Inc. Major Business
Table 55. Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Product and Services
Table 56. Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Baxter International Inc. Recent Developments/Updates
Table 58. Baxter International Inc. Competitive Strengths & Weaknesses
Table 59. Otsuka ICU Medical LLC Basic Information, Manufacturing Base and Competitors
Table 60. Otsuka ICU Medical LLC Major Business
Table 61. Otsuka ICU Medical LLC Peripheral Parenteral Nutrition (PPN) Product and Services
Table 62. Otsuka ICU Medical LLC Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Otsuka ICU Medical LLC Recent Developments/Updates
Table 64. Otsuka ICU Medical LLC Competitive Strengths & Weaknesses
Table 65. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 66. Pfizer Inc. Major Business
Table 67. Pfizer Inc. Peripheral Parenteral Nutrition (PPN) Product and Services
Table 68. Pfizer Inc. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Pfizer Inc. Recent Developments/Updates
Table 70. Pfizer Inc. Competitive Strengths & Weaknesses
Table 71. Otsuka Pharmaceutical Factory, Inc. Basic Information, Manufacturing Base and Competitors
Table 72. Otsuka Pharmaceutical Factory, Inc. Major Business
Table 73. Otsuka Pharmaceutical Factory, Inc. Peripheral Parenteral Nutrition (PPN) Product and Services
Table 74. Otsuka Pharmaceutical Factory, Inc. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Otsuka Pharmaceutical Factory, Inc. Recent Developments/Updates
Table 76. Otsuka Pharmaceutical Factory, Inc. Competitive Strengths & Weaknesses
Table 77. Yoshindo Holdings Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 78. Yoshindo Holdings Co., Ltd. Major Business
Table 79. Yoshindo Holdings Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
Table 80. Yoshindo Holdings Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Yoshindo Holdings Co., Ltd. Recent Developments/Updates
Table 82. Yoshindo Holdings Co., Ltd. Competitive Strengths & Weaknesses
Table 83. Sichuan Kelun Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 84. Sichuan Kelun Pharmaceutical Co., Ltd. Major Business
Table 85. Sichuan Kelun Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
Table 86. Sichuan Kelun Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 88. Sichuan Kelun Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 89. Haisco Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 90. Haisco Pharmaceutical Group Co., Ltd. Major Business
Table 91. Haisco Pharmaceutical Group Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
Table 92. Haisco Pharmaceutical Group Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Haisco Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 94. Haisco Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
Table 95. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 96. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Major Business
Table 97. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
Table 98. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 100. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
Table 101. SSY Group Limited Basic Information, Manufacturing Base and Competitors
Table 102. SSY Group Limited Major Business
Table 103. SSY Group Limited Peripheral Parenteral Nutrition (PPN) Product and Services
Table 104. SSY Group Limited Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. SSY Group Limited Recent Developments/Updates
Table 106. SSY Group Limited Competitive Strengths & Weaknesses
Table 107. Guangdong Otsuka Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 108. Guangdong Otsuka Pharmaceutical Co., Ltd. Major Business
Table 109. Guangdong Otsuka Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
Table 110. Guangdong Otsuka Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Guangdong Otsuka Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 112. Guangdong Otsuka Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 113. China Resources Double-Crane Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 114. China Resources Double-Crane Pharmaceutical Co., Ltd. Major Business
Table 115. China Resources Double-Crane Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
Table 116. China Resources Double-Crane Pharmaceutical Co., Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. China Resources Double-Crane Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 118. China Resources Double-Crane Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 119. JW Life Science Corporation Basic Information, Manufacturing Base and Competitors
Table 120. JW Life Science Corporation Major Business
Table 121. JW Life Science Corporation Peripheral Parenteral Nutrition (PPN) Product and Services
Table 122. JW Life Science Corporation Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. JW Life Science Corporation Recent Developments/Updates
Table 124. JW Life Science Corporation Competitive Strengths & Weaknesses
Table 125. Aculife Healthcare Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 126. Aculife Healthcare Pvt. Ltd. Major Business
Table 127. Aculife Healthcare Pvt. Ltd. Peripheral Parenteral Nutrition (PPN) Product and Services
Table 128. Aculife Healthcare Pvt. Ltd. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Aculife Healthcare Pvt. Ltd. Recent Developments/Updates
Table 130. Aculife Healthcare Pvt. Ltd. Competitive Strengths & Weaknesses
Table 131. Albert David Limited Basic Information, Manufacturing Base and Competitors
Table 132. Albert David Limited Major Business
Table 133. Albert David Limited Peripheral Parenteral Nutrition (PPN) Product and Services
Table 134. Albert David Limited Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Albert David Limited Recent Developments/Updates
Table 136. Albert David Limited Competitive Strengths & Weaknesses
Table 137. Global Key Players of Peripheral Parenteral Nutrition (PPN) Upstream (Raw Materials)
Table 138. Global Peripheral Parenteral Nutrition (PPN) Typical Customers
LIST OF FIGURES
Figure 1. Peripheral Parenteral Nutrition (PPN) Picture
Figure 2. World Peripheral Parenteral Nutrition (PPN) Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Peripheral Parenteral Nutrition (PPN) Total Revenue (2021-2032) & (USD Million)
Figure 4. World Peripheral Parenteral Nutrition (PPN) Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032) & (USD Million)
Figure 13. Peripheral Parenteral Nutrition (PPN) Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032) & (USD Million)
Figure 16. World Peripheral Parenteral Nutrition (PPN) Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032) & (USD Million)
Figure 18. China Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032) & (USD Million)
Figure 23. India Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Peripheral Parenteral Nutrition (PPN) by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Peripheral Parenteral Nutrition (PPN) Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Peripheral Parenteral Nutrition (PPN) Markets in 2025
Figure 27. United States VS China: Peripheral Parenteral Nutrition (PPN) Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Peripheral Parenteral Nutrition (PPN) Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Peripheral Parenteral Nutrition (PPN) Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type in 2025
Figure 31. Single-Chamber Component or Premixed PPN Solutions
Figure 32. Dual-Chamber Ready-to-Use PPN Solutions
Figure 33. Three-Chamber Ready-to-Use PPN Solutions
Figure 34. World Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type (2021-2032)
Figure 35. World Peripheral Parenteral Nutrition (PPN) Market Size by Osmotic Pressure Level, (USD Million), 2021 & 2025 & 2032
Figure 36. World Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Osmotic Pressure Level in 2025
Figure 37. Low-Osmolarity PPN Solutions: below 600 mOsm/L
Figure 38. Standard Peripheral PPN Solutions: 600 to below 750 mOsm/L
Figure 39. Upper Peripheral-Limit PPN Solutions: 750 to 900 mOsm/L
Figure 40. World Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Osmotic Pressure Level (2021-2032)
Figure 41. World Peripheral Parenteral Nutrition (PPN) Market Size by Combination of Main Nutrients, (USD Million), 2021 & 2025 & 2032
Figure 42. World Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Combination of Main Nutrients in 2025
Figure 43. Amino Acid and Glucose PPN Solutions
Figure 44. Amino Acid, Glucose and Electrolyte PPN Solutions
Figure 45. Amino Acid, Glucose, Electrolyte and Vitamin PPN Solutions
Figure 46. Amino Acid, Glucose, Lipid and Electrolyte PPN Solutions
Figure 47. Amino Acid, Glucose, Lipid, Electrolyte and Vitamin PPN Solutions
Figure 48. Single-Nutrient PN Component Solutions Used for PPN Compounding
Figure 49. World Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Combination of Main Nutrients (2021-2032)
Figure 50. World Peripheral Parenteral Nutrition (PPN) Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application in 2025
Figure 52. Hospital
Figure 53. Home
Figure 54. World Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application (2021-2032)
Figure 55. Peripheral Parenteral Nutrition (PPN) Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
Figure 1. Peripheral Parenteral Nutrition (PPN) Picture
Figure 2. World Peripheral Parenteral Nutrition (PPN) Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Peripheral Parenteral Nutrition (PPN) Total Revenue (2021-2032) & (USD Million)
Figure 4. World Peripheral Parenteral Nutrition (PPN) Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Peripheral Parenteral Nutrition (PPN) Revenue (2021-2032) & (USD Million)
Figure 13. Peripheral Parenteral Nutrition (PPN) Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032) & (USD Million)
Figure 16. World Peripheral Parenteral Nutrition (PPN) Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032) & (USD Million)
Figure 18. China Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032) & (USD Million)
Figure 23. India Peripheral Parenteral Nutrition (PPN) Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Peripheral Parenteral Nutrition (PPN) by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Peripheral Parenteral Nutrition (PPN) Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Peripheral Parenteral Nutrition (PPN) Markets in 2025
Figure 27. United States VS China: Peripheral Parenteral Nutrition (PPN) Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Peripheral Parenteral Nutrition (PPN) Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Peripheral Parenteral Nutrition (PPN) Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type in 2025
Figure 31. Single-Chamber Component or Premixed PPN Solutions
Figure 32. Dual-Chamber Ready-to-Use PPN Solutions
Figure 33. Three-Chamber Ready-to-Use PPN Solutions
Figure 34. World Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type (2021-2032)
Figure 35. World Peripheral Parenteral Nutrition (PPN) Market Size by Osmotic Pressure Level, (USD Million), 2021 & 2025 & 2032
Figure 36. World Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Osmotic Pressure Level in 2025
Figure 37. Low-Osmolarity PPN Solutions: below 600 mOsm/L
Figure 38. Standard Peripheral PPN Solutions: 600 to below 750 mOsm/L
Figure 39. Upper Peripheral-Limit PPN Solutions: 750 to 900 mOsm/L
Figure 40. World Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Osmotic Pressure Level (2021-2032)
Figure 41. World Peripheral Parenteral Nutrition (PPN) Market Size by Combination of Main Nutrients, (USD Million), 2021 & 2025 & 2032
Figure 42. World Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Combination of Main Nutrients in 2025
Figure 43. Amino Acid and Glucose PPN Solutions
Figure 44. Amino Acid, Glucose and Electrolyte PPN Solutions
Figure 45. Amino Acid, Glucose, Electrolyte and Vitamin PPN Solutions
Figure 46. Amino Acid, Glucose, Lipid and Electrolyte PPN Solutions
Figure 47. Amino Acid, Glucose, Lipid, Electrolyte and Vitamin PPN Solutions
Figure 48. Single-Nutrient PN Component Solutions Used for PPN Compounding
Figure 49. World Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Combination of Main Nutrients (2021-2032)
Figure 50. World Peripheral Parenteral Nutrition (PPN) Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application in 2025
Figure 52. Hospital
Figure 53. Home
Figure 54. World Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application (2021-2032)
Figure 55. Peripheral Parenteral Nutrition (PPN) Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
